Identification of galactosamine-(N-acetyl)-6-sulfatase (GALNS) as a novel therapeutic target in progression of nasopharyngeal carcinoma.
- Resource Type
- Article
- Source
- Discover Oncology; 9/14/2023, Vol. 14 Issue 1, p1-11, 11p
- Subject
NASOPHARYNX cancer CANCER invasiveness SULFATASES - Language
- ISSN
- 27306011